About Trevigen
Trevigen is a company based in Gaithersburg (United States) founded in 1992 was acquired by Bio-Techne in September 2017. Trevigen offers products and services including Cultrex Basement Membrane Matrix, CometAssay, iCE Maurice, and TACS Annexin V-FITC Kit. Trevigen operates in a competitive market with competitors including Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter Gaithersburg, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website trevigen.com
- Social LinkedIn X Facebook YouTube
- Acquired by Bio-Techne (Sep 2017)
- Latest Funding Round$216.88K (USD), Grant
Mar 2012
- InvestorsBio-Techne
& 1 more
- Acquired byBio-Techne
(Sep 2017)
Products & Services of Trevigen
Trevigen offers a comprehensive portfolio of products and services, including Cultrex Basement Membrane Matrix, CometAssay, iCE Maurice, and TACS Annexin V-FITC Kit.
Matrix for expanding and maintaining stem cells in vitro
Technique for quantifying DNA damage and repair in cells
Instrument for imaging and analyzing cell behavior
Kit for detecting early apoptosis events in cells
Apps and channels of Trevigen
its YouTube channel Bio-Techne has 509 subscribers and 30 videos.
Videos from Trevigen
The most watched videos on Trevigen's YouTube channel, Bio-Techne (509 subscribers). Click a video to play it here.
More on Bio-Techne.
Funding Insights of Trevigen
- Total Rounds 2
- Last Round Grant — $216,878
- First Round $2.53M
(Sep 2010)
- Investors Count 1
All 2 funding rounds of Trevigen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Trevigen
Trevigen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bio-Techne and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Developer of biotech reagents, instruments and clinical diagnostic products | 1981 | bio-techne.com | Minneapolis, United States |
Investor details for Trevigen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Trevigen
4 dated milestones of Trevigen across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Trevigen is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Grant, of $217K.
- Exit Acquired by Bio-Techne.
Competitors of Trevigen
Trevigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| thermofisher.com | 1956 | Waltham, United States | – | 75,000 | Electron microscopy services and microanalysis instruments are provided. | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. |
Detailed competitors of Trevigen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Trevigen
Websites that share an audience with Trevigen (trevigen.com).
Websites whose visitors overlap most with Trevigen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ebioscience.com | 100% | – | – | View details | |
| rndsystems.com | 95% | 349K | #159,292 | View details | |
| scbt.com | 93% | 444.3K | #138,937 | View details | |
| amsbio.com | 84% | 59.3K | #613,920 | View details | |
| abnova.com | 83% | 30.7K | #957,320 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Trevigen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Trevigen
10 companies that operate in the same segment as Trevigen (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trevigen
Trevigen was founded in 1992 and raised its 1st funding round 18 years after it was founded.
Trevigen is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Trevigen offers products and contract services for biotech research with a focus on cell stress DNA damage. Their products include the COMET assay for detection of DNA damage and repair from animal and plant cells, the FLARE assay for measuring oxidative DNA damage in cells and the 96-well CometChip System for high-throughput treatment and measurement of DNA damage. The company produces reagents as well as instrumentation and software for the assays, including the Electrophoresis System that works with both CometAssay, FLARE, and CometChip products. Trevigen also manufactures extracellular matrix proteins, and ECM protein-coated labware for cell culture, assays such as angiogenesis and vascular integrity assays, cell migration assays, cell invasion assays, 3D cell culture and organoid culture products, and stem cells for research.
Trevigen's top competitors include Thermo Fisher Scientific, Biocare Medical and Merck.
Trevigen offers Cultrex Basement Membrane Matrix, CometAssay, iCE Maurice, and TACS Annexin V-FITC Kit.
Trevigen has 2 investors. Key investors include Bio-Techne, and HHS.
Yes. Trevigen was acquired by Bio-Techne in September 2017.